Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saputo Dairy UK, formerly known as Dairy Crest, is a prominent British dairy processor that has significantly expanded into the life sciences and functional ingredients sector. The company is a leading producer of galacto-oligosaccharides (GOS), a high-value prebiotic ingredient used in infant formula to support gut health and immune system development. Operating from its specialized facility in Davidstow, Cornwall, the company utilizes advanced enzymatic processes to convert lactose into nutritional components for the global market. While it maintains a strong presence in the consumer food sector with brands like Cathedral City, its strategic focus on demineralized whey and prebiotics positions it as a key supplier in the nutraceutical industry. The company was acquired by the Canadian dairy giant Saputo Inc. in 2019 for approximately £975 million. It continues to innovate in the field of early-life nutrition through partnerships with global dairy leaders like Fonterra.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dairy Crest.